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HIGHLIGHTS
•  This is the first report of motor recovery after a seizure induced by high-frequency 
repetitive transcranial magnetic stimulation (rTMS).
• The hand strength and coordination were improved after seizure induced by rTMS.
• Rarely, neurologic recoveries are reported rather than deteriorations after seizures.




Received: Feb 23, 2019
Revised: Mar 14, 2019
Accepted: Mar 19, 2019
Correspondence to
Yoon Ghil Park
Department of Rehabilitation Medicine, 
Gangnam Severance Hospital, Yonsei 
University, 20 Eonju-ro 63-gil, Gangnam-gu, 
Seoul 06229, Korea.
E-mail: DRTLC@yuhs.ac
Jinyoung Park, Young Seok Kim, Eu Jeong Ko, Yoon Ghil Park
Motor Recovery after Seizure Induced 






Despite the low incidence, seizures induced by repetitive transcranial magnetic stimulation 
(rTMS) have been studied as they may cause neurological and functional regression. Seizures 
may predict poor outcomes in stroke patients, with no reports of improved neurological 
status after seizures. This is the first Korean report of a seizure induced by rTMS, and the 
first report in the literature of prompt motor recovery following a seizure induced by high-
frequency rTMS of the primary motor cortex in a stroke patient. A 43-year-old man with left 
hemiplegia due to infarction in the right basal ganglia was enrolled 10 sessions of rTMS (each 
session consisted of 15 trains, with each train consisting of 5 seconds of stimulation at 20 
Hz and 90% of resting motor threshold for each session followed by 55 seconds of rest). The 
self-limited seizure occurred within 5 seconds after the 10th session. It lasted for 60 seconds, 
with generalized tonic features in all four extremities and the trunk and loss of consciousness 
followed by prompt improvement in left hand muscle strength and coordination. Though 
the seizure is known to usually cause neurologic regression, this case showed neurologic 
improvement after rTMS even after the rTMS-induced seizure.
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INTRODUCTION
Since its introduction in 1984, repetitive transcranial magnetic stimulation (rTMS) has been 
studied in patients with stroke, spinal cord injury, depression, epilepsy, and pain, and some 
results remain controversial. There has also been extensive discussion on ethical issues and 
safety. With focus on motor recovery after stroke, protocols are generally divided into high-
frequency and low-frequency rTMS. Low-frequency rTMS at 1 Hz inhibits the brain cortex, 
and high-frequency rTMS at 10 Hz or more stimulates the cortex. Thus, seizures have been 
among the concerning adverse effects of high-frequency rTMS, but not many cases have been 
reported. This is the first report in the literature of prompt motor recovery and improved motor 
coordination following a seizure provoked by high-frequency rTMS of the primary motor cortex.
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A 43-year-old man had sudden dysarthria with left upper and lower extremity weakness on 
March 7, 2016. He arrived in the emergency room 1 hour after onset. He was alert, with no 
epileptic activity or loss of consciousness. Manual muscle testing showed poor minus grade 
to poor plus grade in left side (Table 1). He could not move his left thumb opposite to the 
second-fifth fingers. He also had a sensory deficit to light touch, pain, temperature, and 
proprioception on his left side. After the computed tomography (CT) revealed intracerebral 
hemorrhage (ICH) in the right basal ganglia (Fig. 1), he was admitted to the Department of 
Neurosurgery. Intravenous mannitol was promptly started. Oral levetiracetam to prevent 
post-hemorrhagic seizure was started with 1,000 mg/day next day. As CT angiography 6 hours 
after the initial scan revealed no interval change in the amount of hemorrhage or a midline 
shift, he was treated without surgery. Brain magnetic resonance image on the seventh day 
after onset showed focal left distal vertebral arterial stenosis with subacute ICH in the right 
basal ganglia. On the transfer day to the Department of Physical Medicine and Rehabilitation 
on March 19, the motor grades of the left shoulder and elbow were to poor plus, and thus, he 
needed moderate assistance with activities of daily living. He was enrolled in a rehabilitation 
program including physical therapy for strengthening and gait training, and occupational 
therapy to improve hand function. When examined on March 28, he showed fair grade in 
the left upper extremity, except for fair minus grade in left finger flexion and extension, and 
fair minus grade in the left lower extremity. As he had no seizure or seizure-like events, we 
gradually reduced the dosage of levetiracetam to 500 mg/day on March 26, 250 mg/day on 
April 6, and tapered off by April 11.
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Table 1. Serial manual muscle testing and the Medical Research Council scales
Region Before the seizure After the seizure
03.08.2016 03.19.2016 03.28.2016 04.16.2016 04.18.2016 04.19.2016 04.21.2016 06.21.2016
Shoulder
Fl N/P N/P+ N/F N/F N/F N/F N/F N/G
Ex N/P N/P+ N/F N/F N/F N/F N/F N/G
Ab N/P N/P+ N/F N/F N/F N/F N/F N/G
Ad N/P N/P+ N/F N/F N/F N/F N/F N/G
Elbow
Fl N/P N/P+ N/F N/F N/F N/F N/F N/G
Ex N/P N/P+ N/F N/F N/F N/F N/F N/G
Wrist
Fl N/P+ N/P+ N/F N/F N/F N/F N/F N/G
Ex N/P+ N/P+ N/F N/F N/F N/F N/F N/G
Finger
Fl N/P+ N/P+ N/F− N/F− N/G* N/F+† N/F+ N/G
Ex N/P+ N/P+ N/F− N/F− N/F+* N/F+ N/F+ N/G
Hip
Fl N/P N/P− N/F− N/F− N/F* N/F N/F N/G
Ex N/P N/P− N/F− N/F− N/F* N/F N/F N/G
Ab N/P N/P− N/F− N/F− N/F* N/F N/F N/G
Ad N/P N/P− N/F− N/F− N/F* N/F N/F N/G
Knee
Fl N/P N/P− N/F− N/F− N/F* N/F N/F N/G
Ex N/P N/P− N/F− N/F− N/F* N/F N/F N/G
Ankle
Df N/P− N/P− N/F− N/F− N/F− N/F− N/F− N/G
Pf N/P− N/P− N/F− N/F− N/F− N/F− N/F− N/G
Fl, flexion; Ex, extension; Ab, abduction; Ad, adduction; Df, dorsiflexion; Pf, plantar flexion; N, normal; G, good; F+, fair plus; F, fair; F−, fair minus; P+, poor plus; 
P, poor; P−, poor minus.
*Prompt increase in muscle power after post-ictal state on the day the seizure occurred; †Decrease in power 1 day after the seizure, but still increased compared 
to before the seizure.
High-frequency rTMS was started on April 4, and the last of the 10 sessions was completed 
on April 18. The patient was placed in a stable and comfortable position in a chair, and fixed 
posture was maintained throughout the procedure. Stimulation was applied using a figure-
eight coil, MC-B70 (MagVenture, London, UK) connected to MagPro R30 (MagVenture), 
positioned over the primary motor hot spot of the affected hemisphere. Each session 
consisted of 15 trains, and each train consisted of 5 seconds at 20 Hz and 90% of the resting 
motor threshold (RMT) stimulations followed by 55 seconds of rest. The RMT was defined 
as the minimum stimulatory intensity necessary to elicit >50 μV of motor response in the 
right abductor digiti minimi muscle on 5 out of 10 consecutive trials. The measured RMT 
was 60% of maximum coil output. When stimulated with 90% RMT, the right cortex showed 
maximum 0.2 mV of amplitude/minimum 24.8 ms of onset latency, where the left cortex 
showed maximum 2.3 mV/21.3 ms. It was performed by one skilled physician. At each 
session, he was observed for 15 minutes to confirm stability without complications.
The Medical Research Council scale was used by one physician to assess muscle power. Thumb 
opposition was used to evaluate fine motor function, and the Kapandji score was determined 
for each evaluation. Power was measured with a hand dynamometer and pinch gauge 
(Baseline®; Fabrication Enterprises, Inc., New York, NY, USA) by one skilled occupational 
therapist. In addition to these objective tests, patient's own report was also considered.
Seizure induced by rTMS
The seizure occurred within 5 seconds after finishing the 10th session of rTMS. The patient 
showed generalized tonic features in all four extremities with loss of consciousness. The head 
was turned to the right, and the eyeballs were deviated to the right. The self-limited seizure 
lasted 60 seconds. Brain CT only showed the old focal lesion in the right basal ganglia. Oral 
levetiracetam of 500 mg/day restarted. Electroencephalography (EEG) evaluated on the day 
of seizure was normal, with no interictal epileptiform discharge. He kept the medication for 
2 weeks and quit by himself after discharge, but there was no additional seizure event over 2 
years. The following EEG evaluated 2 years after the seizure also showed normal.
Functional gain after seizure induced by rTMS
After the post-ictal state passed, he reported that he could make a left fist within 10 seconds 
before the seizure, for the first time since the stroke. Neurologic examination 6 hours after 
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Fig. 1. Brain computed tomography revealed intracerebral hemorrhage in the right basal ganglia.
the episode showed much improved left-hand strength. Left finger flexion was good grade 
and extension was fair plus. Two days before seizure, he could oppose his left thumb to 
the second-third, but not the fourth-fifth fingertips. However, he could easily move his left 
thumb to the fourth finger tips with much separated movement on April 18, following the 
post-ictal phase, and the Kapandji score improved from 4 to 5 (Table 2). Although he had 
no spasticity since the stroke, he showed dysregulated synergic flexion pattern in the left 
fingers. He could not independently flex his first and second fingers after the stroke, but he 
could make immediately following the seizure. Grip strength (from 6.0 to 10.0 kg) and lateral 
pinch power (from unmeasurable to 3.0 kg) was improved on April 22 compared to March 15. 
Furthermore, he reported that he could make these movements with greater power within 5 
seconds before he lost consciousness.
On April 19, he reported that hand power and coordination were definitely improved compare 
with prior to the seizure, but not as much as immediately following the post-ictal phase. 
Finger flexion power decreased to fair plus from good, but this was improved compared to 
before the seizure.
He transferred to another rehabilitation hospital on April 21, and left upper and lower 
extremity strength continued to improve. When examined in the outpatient clinic on June 21, 
strength was improved to good grade in all left-side muscle groups.
DISCUSSION
There have been numerous attempts to reproduce or regenerate nerves in central nervous 
system (CNS). CNS neuromodulation research began long before the human stem cell 
research that began in 1978. Similar to the preceding transcranial direct current stimulation 
and electroconvulsive therapy, transcranial magnetic stimulation (TMS) raised major ethical 
concerns. Despite being non-invasive, several side effects were reported, including nausea, 
epistaxis, dizziness, headache, tinnitus, vision problems, hearing loss, and seizures. The 
U.S. Food and Drug Administration (FDA) approved TMS in 2008. The FDA subsequently 
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Table 2. Hand power and function
Variables Before the seizure After the seizure
03.15.2016 04.16.2016 04.18.2016 04.22.2016 06.21.2016
Thumb opposition test (tip to tip)
Second finger +/− +/+ +/+ +/+ +/+
Third finger +/− +/+ +/+ +/+ +/+
Fourth finger +/− +/− +/+* +/+ +/+
Fifth finger +/− +/− +/− +/− +/+
Kapandji score 2 4 5* 5 8
Grip strength (kg)
Right 32.0 32.0 41.0
Left 6.0 10.0 28.0
Lateral pinch power (kg)
Right 9.5 8.5 11.0
Left um 3.0 8.2
Tip pinch power (kg)
Right 5.0 3.0 7.0
Left um um 4.5
um, unmeasurable due to weakness.
*Prompt increase in finger power.
issued a “Class II Special Controls Guidance Document for rTMS Systems” including a table 
named “Maximum Safe Train Duration (seconds) Limits for Avoiding Seizure” on July 26, 
2011. Despite this guidance, some clinical reports of high-frequency rTMS which did not 
follow the protocol demonstrated effectiveness without complications. Khedr et al. [1,2] 
reported pain relief in trigeminal neuralgia or post-stroke pain syndrome (20 Hz, 80% RMT, 
10 trains, 10-second train duration, 2,000 pulses/session, 5 sessions for 5 consecutive days), 
and improved motor performance in Parkinson's disease after high frequency rTMS (25 
Hz, 100% RMT, 10 trains, 4-second train duration, 1,000 pulses/session, 6 sessions for 6 
consecutive days). Ahmed et al. [3] showed phantom pain relief with high frequency rTMS 
(20 Hz, 80% RMT, 10 trains, 5-second train duration, 1,000 pulses/session, 5 sessions for 
5 consecutive days). Hausmann et al. [4] showed no adverse effect including seizure when 
applied high frequency rTMS to the depressive patients (20 Hz, 100% RMT, 10 trains, 
10-second train duration, 2,000 pulses/session, 10 sessions for 2 × 5 days). However, a recent 
report described a seizure following low-frequency rTMS despite compliance with FDA 
guidance [5]. In our study, although the therapeutic design (20 Hz, 90% RMT, 15 trains, 
5-second train duration, 1,500 pulses/session, 10 sessions for 2 × 5 days) was against the U.S. 
FDA guidance, it was among the previous therapeutic boundary of which the out-of-guideline 
studies showed promising outcomes or at least not caused severe adverse effects. However, 
this protocol led to the seizure event. As he had no lesion other than in the basal ganglia, and 
there had been no epileptic episode, spontaneous seizure was unexpected. Thus, we assumed 
that the seizure was due to the cumulative effect of rTMS.
Moreover, the patient had no neurologic regression after the seizure, but showed improved 
muscle strength and hand function. This is distinct from previous reports of seizure 
following rTMS. Dobek et al. summarized all 25 seizure events reported as of September, 
2015, and none showed motor recovery or improved coordination after the seizures [6]. 
However, there have been some reports of neurologic improvement other than motor 
recovery. Bagati et al. [7] reported a patient with improvement in depression 3 days after 
the rTMS-induced seizure. Another case with adolescent-onset major depressive disorder 
showed hypomania for only 1 night after an rTMS-induced seizure [8]. Whereas, Fauth et al. 
[9] reported a patient with left middle cerebral artery infarction who had 4 days of postictal 
paresis. However, the neurologic improvement after rTMS-induced seizure could be a 
separate sole result of rTMS, not of the seizure. Thus, there can be a logical leap to judge the 
neurologic improvement as a result of rTMS-induced seizure.
While thumb opposition was tested on April 16 and 18, strength was measured by the 
devices on March 15, April 22, and June 21. This is a limitation of this report, since the 
power measurement was not performed closer to the day of the seizure (Table 2). However, 
considering the results of manual motor test and more separated movement after post-ictal 
state, prompt measurement also would have shown each improved power, if performed.
As conclusion, this is the first report of prompt motor recovery after seizure induced by 
high-frequency rTMS. Although this patient showed no other neurologic adverse effects, 
considering the potential negative consequences of seizure, high-frequency rTMS should be 
carefully applied based on safety consensus. Through the cumulative results of the protocols 
which reported with a slightly off-line guideline so far, more precise information for more 
effective and safe rTMS would be obtained.
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